Calpain-10 gene polymorphism in type 2 diabetes mellitus patients in the gaza strip

Medical Principles and Practice

Volumn 19, Issue 6, 2010, Pages 457-462

  Zaharna, Mazen M ^a   Abed, Abdalla A ^a   Sharif, Fadel A ^a  

^a ISLAMIC UNIVERSITY OF GAZA   (Palestine)

Author keywords

Calpain 10; Cholesterol; Gaza Strip; Triglycerides; Type 2 diabetes mellitus

Indexed keywords

CALPAIN 10; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGAR GEL ELECTROPHORESIS; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; ARABS; CALPAIN; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MIDDLE EAST; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TRIGLYCERIDES;

EID: 77957655710     PISSN: 10117571     EISSN: None     Source Type: Journal    
DOI: 10.1159/000320304     Document Type: Article

References (23)

1. Hansen T: Genetics of type 2 diabetes. Curr Sci 2002; 83:1477-1482.
2. Gavin JR, Alberti KG, Davidson MB, De-Fronzo RA, Drash A, Gabbe SG, Genuth S, Harris MI, Kahn R, Keen H, Knowler WC, Lebovitz H, Maclaren NK, Palmer JP, Raskin P, Rizza RA, Stern MP: Report of the expert committee on the diagnosis and classifi-cation of diabetes mellitus. Diabetes Care 2002; 25:S5-S20.
3. Venkat Narayan KM, Zhang P, Kanaya AM, Williams DE, Engelgau MM, Imperatore G, Ramachandran A: Diabetes: the pandemic and potential solutions; in Jamison DT, World Bank, Disease Control Priorities Proj-ect (eds): Disease Control Priorities in De-veloping Countries, ed 2. New York, Oxford University Press, 2006, pp 591-593.
4. Ministry of Health-Palestine Health Information Center (MOH-PHIC): Non-commu-nicable diseases: health status in Palestine 2005. 2006.
5. Das SK: Genetic epidemiology of adult onset type 2 diabetes in Asian Indian population: past, present and future. Int J Hum Genet 2006; 6:1-13.
6. Toye A, Gauguier D: Genetics and function-al genomics of type 2 diabetes mellitus. Ge-nome Biol 2003; 4: 241.1-241.4.
7. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Me-lander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, Bosque-Plata LB, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000; 26: 163-175.
8. Carlsson E, Fredriksson J, Groop L, Ridder-strale M: Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribo-nucleic acid expression in obese Swedish subjects. J Clin Endocrinol Metab 2004; 89: 3601-3605.
9. Daimon M, Oizumi T, Saitoh T, Kameda W, Yamaguchi H, Ohnuma H, Yamaguchi H Ohnuma H, Igarashi M, Manaka H, Kato T: Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res Clin Pract 2002; 56: 147-152.
10. Marshall C, Hitman GA, Partridge CJ, Clark A, Ma H, Shearer TR, Turner MD: Evidence that an isoform of calpain-10 Is a regulator of exocytosis in pancreatic β-cells. Mol Endo-crinol 2005; 19: 213-224.
11. Suzuki K, Hata S, Kawabata Y, Sorimachi H: Structure, activation, and biology of calpain. Diabetes 2004; 53:S12-S18.
12. Rasmussen SK, Urhammer SA, Berglund L, Jensen JN, Hansen L, Echwald SM, Borch-Johnsen K, Horikawa Y, Mashima H, Lithell H, Cox NJ, Hansen T, Bell GI, Pedersen O: Variants within the calpain-10 gene on chro-mosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes 2002; 51: 3561-3567.
13. Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, Walker M, Levy JC, O'Rahilly S, Subba Rao PV, Bennett AJ, Jones EC, Men-zel S, Prestwich P, Simecek N, Wishart M, Dhillon R, Fletcher C, Millward A, Demaine A, Wilkin T, Horikawa Y, Cox NJ, Bell GI, Ellard S, McCarthy MI, Hattersley AT: Stud-ies of association between the gene for cal-pain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 2001; 69: 544-552.
14. Malecki MT, Moczulski DK, Klupa T, Wanic K Cyganek K, Frey J, Sieradzki J: Homozy-gous combination of calpain 10 gene haplo-types is associated with type 2 diabetes mel-litus in a Polish population. Eur J Endocrinol 2002; 146: 695-699.
15. Weedon MN, Schwarz PE, Horikawa Y, Iwa-saki N, Illig T, Holle R Rathmann W, Selisko T, Schulze J, Owen KR, Evans J, Bosque-Plata LD, Hitman G, Walker M, Levy JC, Sampson M, Bell GI, McCarthy MI, Hattersley AT, Frayling TM: Meta-analysis and a large as-sociation study confirm a role for calpain-10 variation in type 2 diabetes susceptibility Am J Hum Genet 2003; 73: 1208-1212.
16. Tsuchiya T, Schwarz P, Bosque-Plata L, Geoffrey Hayes M, Dina C, Froguel P, Wayne Towers G, Fischer S, Temelkova-Kurktschiev T, Rietzsch H, Graessler J, Vcelák J, Palyzová D, Selisko T, Bendlová B, Schulze J, Julius U, Hanefeld M, Weedon MN, Evans JC, Fray-ling TM, Hattersley AT, Orho-Melander M, Groop L, Malecki MT, Hansen T, Pedersen O, Fingerlin TE, Boehnke M, Hanis CL, Cox NJ, Bell GI: Association of the calpain-10 gene with type 2 diabetes in Europeans: re-sults of pooled and meta-analysis. Mol Genet Metab 2006;89:174-184.
17. Cassell PG, Jackson AE, North BV, Evans JC, Syndercombe-Court D, Phillips C, Rama-chandran A, Snehalatha C, Gelding SV, Vi-jayaravaghan S, Curtis D, Hitman GA: Hap-lotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes 2002; 51: 1622-1628.
18. Wu B, Takahashi J, Fu M, Cheng H, Mat-sumura S, Taniguchi H: Variants of cal-pain-10 gene and its association with type 2 diabetes mellitus in a Chinese population. Diabetes Res Clin Pract 2005; 68:155-161.
19. Fingerlin TE, Erdos MR, Watanabe RM, Wiles KR, Stringham HM, Mohlke KL, Si-lander K, Valle TT, Buchanan TA, Tuomileh-to J, Bergman RN, Boehnke M, Collins FS: Variation in three single nucleotide poly-morphisms in the calpain-10 gene not asso-ciated with type 2 diabetes in a large Finnish cohort. Diabetes 2002; 51: 1644-1648.
20. Tsai HJ, Sun G, Weeks DE, Kaushal R, Wolu-jewicz M, McGarvey ST, Tufa J, Viali S, Deka R: Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association. Am J Hum Genet 2001;69:1236-1244.
21. Horikawa Y, Oda N, Yu LI, Imamura S, Fuji-wara K Makino M, Seino Y, Itoh M, Takeda J: Genetic variations in calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese. J Clin Endocrinol Metab 2003; 88: 244-247.
22. Song Y, Niu T, Manson JE, Kwiatkowski DJ, Liu S: Are variants in the CAPN10 gene re-lated to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. Am J Hum Genet 2004; 74:208-222.
23. Thompson MW, Nussbaum RL, McInnes RR, Willard HF, Thompson JS, Boerkoel CF III: Thompson and Thompson Genetics in Medicine, ed 7. New York, Saunders, 2007, pp 199-200.